--2025/Q1-- / 3.630B--
--2024/Q4-- / 3.753B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 742.575
- +4.575+0.62%
Trading Nov 25 12:30 ET
81.60BMarket Cap18.37P/E (TTM)
757.495High741.620Low445.99KVolume747.970Open738.000Pre Close334.32MTurnover0.42%Turnover Ratio21.36P/E (Static)109.89MShares1211.20052wk High2.78P/B78.27BFloat Cap735.95552wk Low--Dividend TTM105.41MShs Float1211.200Historical High--Div YieldTTM2.15%Amplitude4.610Historical Low749.625Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
Regeneron Pharmaceuticals Q3 2024 Earnings Date
Currency：USDOct 31, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 3.67B | 3.72B | +53.88M |
| Beat Est. | +9.04% | +10.65% | +1.47% |
| EPS | 9.58 | 11.54 | +1.96 |
| Beat Est. | +7.81% | +29.81% | +20.41% |
Analyst Rating
Nov 14, 2024
Regeneron Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Regeneron Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
